Prediction of Acute Toxicity Grade ≥ 3 in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Intensity Modulated Radiotherapy and Concurrent Low-Dose Cisplatin

Concurrent low-dose cisplatin using IMRT is effective in a large cohort of consecutive patients with NSCLC and life threatening toxicity is rare (1%). PS ≥ 2 and V50oes are correlated with acute toxicity grade ≥ 3.